Surgical treatment of Siewert II adenocarcinoma of the esophagogastric junction.
- Author:
Yun-sheng QIN
1
;
Ye-zhong ZHUANG
;
Jie-sheng YANG
;
Chu-jian HUANG
;
Qiang-zhou XU
;
Mian-sheng HUANG
Author Information
- Publication Type:Journal Article
- MeSH: Adenocarcinoma; surgery; Aged; Esophagogastric Junction; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome
- From: Chinese Journal of Gastrointestinal Surgery 2012;15(9):910-912
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the outcomes after surgical treatment of esophagogastric junction carcinoma (EGJC).
METHODSOne hundred and eighty-five patients with EGJC undergoing surgery from October 2000 to September 2006 at the Cancer Hospital of Shantou University were reviewed retrospectively. The clinical outcomes were compared between transthoracic and transabdominal approach.
RESULTSOf the 185 patients, 133 underwent operation via transthoracic approach and 52 via transabdominal approach. The postoperative complication rates were 10.5%(14/133) and 11.5%(6/52) and the 1-, 3-, 5-year overall survival rates were 83.9%, 44.5%, 32.9% and 86.0%, 38.0%, 30.0% in transthoracic and transabdominal groups respectively, and the difference were not statistically significant (both P>0.05).
CONCLUSIONSurgical approach should be individualized for EGCJ.
